Physician profile
Kirstin Anastasia
NPI 1639203979
$974.77
in general payments reported to CMS, 2019-2025
15 companies · $636 in 2025
The $636 reported for 2025 was more than what a typical Psychiatric/Mental Health, Child & Adolescent (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $315).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $63.86 · 2024: $275 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $974.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $205.07 | 2024-2025 | Caplyta |
| Corium, LLC | $185.45 | 2024-2025 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $89.14 | 2023-2024 | Rexulti, Nuedexta |
| Alkermes, INC. | $82.34 | 2025 | Lybalvi, Aristada, Vivitrol |
| Abbvie INC. | $72.56 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $54.57 | 2024-2025 | Spravato |
| Teva Pharmaceuticals USA, INC. | $49.12 | 2024-2025 | Austedo Xr, Austedo Xr |
| Lundbeck LLC | $42.63 | 2025 | Rexulti |
| Tms Neurohealth Centers INC. | $41.56 | 2025 | Tms Neurohealth Centers INC. |
| Indivior INC. | $38.05 | 2025 | Sublocade |
| Braeburn INC. | $35.68 | 2025 | Brixadi |
| Takeda Pharmaceuticals U.S.A., INC. | $23.05 | 2025 | Trintellix |
| Collegium Pharmaceutical, INC. | $19.00 | 2025 | Jornay Pm |
| Neurocrine Biosciences, INC. | $18.56 | 2025 | |
| Idorsia Pharmaceuticals US INC | $17.99 | 2024 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kirstin Anastasia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.